Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age
Clinical trial NCT01857206 · COMPLETED
Trial details
- NCT number
- NCT01857206
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-06-01
- Enrollment
- 2055
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.